Case Studies & Testimonials

Read some testimonials left by patients and case studies of our previous trials.

You can plan a clinical trial meticulously but when you start a First-in-Human study prepare to be flexible!

Richmond Pharmacology has extensive experience of conducting First-in-Human clinical trials, including studies involving biologics, and we have a very experienced team on hand to help you. You can be sure we will rise to the occasion.

View Case Study

Data Management Case Study - April 09

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

Data Management Case Study - March 09

Timelines, Tight Timelines, And Even Tighter Timelines In A Phase I Environment.

View Case Study

The Richmond Pharmacology Japanese Team commits to a challenging study...and they deliver.

Richmond Pharmacology has extensive experience in the conduct of intensive thorough QTc studies. We are proud to offer a dedicated, highly skilled team within an efficient and safe hospital environment, using state of the art technology.

View Case Study

65 Subjects Vaccinated in 1 day

Recruitment can sometimes be a challenge, however the tighter the timelines and the larger the group required, the more Richmond Pharmacology rises to the challenge.

View Case Study

“I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.”

- Anonymous

“Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.”

- Anonymous

“Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.”

- Anonymous

Latest news

Upcoming Event

EUFEMED, 3rd Annual Conference, 28-30 April 2021

28-30 April 2021
Dr Jorg Taubel will co-chair a session on day one, which explores how technology has reduced the risks of pandemic effects on Phase I and II trial performance.
View event

What 20 years of clinical research has taught us about our industry and the future of drug development

June 9, 2021
As Richmond Pharmacology approaches its 20th anniversary our co-founder and CEO reflects on the developments, regulatory changes, and innovations within the life science industry in an article in the PharmaTimes.
Read more

Do we still need challenge trials with COVID-19?

April 21, 2021
Nir Eyal and colleagues suggested that the initiation of COVID-19 challenge trials in response to the UK governments’ call in 2020 remained relevant and important despite the development of approved vaccines and the introduction of an aggressive, UK-wide vaccination policy.
Read more

Novel rate-controlled fentanyl patch shows promise in phase I clinical trial

April 1, 2021
Our expertise in ethnic differences and access to over 12,000 first generation Japanese volunteers accelerated our ability to provide robust clinical trial data to support future applications of new chronic pain medicines to the Japanese drug market.
Read more